New Study With Victoza® (Liraglutide) Showed Improvements in Blood Glucose Control in Adults With Type 2 Diabetes Who Fasted During Ramadan

Novo Nordisk A/S [Pressemappe]
Boston, Massachusetts (ots/PRNewswire) – This material is intended for medical non-UK media only. For journalistic assessment and preparation before publication Abstract #1121-P New findings showed that adults with type 2 diabetes treated with … Lesen Sie hier weiter…

Ähnliche Beiträge:

  • Sanofi’s Lyxumia® (lixisenatide) Showed More…
  • Canagliflozin Provided Substantial and Sustained Glycemic…
  • TEENs Study Shows Achieving Target Blood Sugar Levels is…
  • Die auf dem jährlichen Treffen der European Association for
  • Sanofi Announces Positive Phase 3 Results for Toujeo®…